Trust Company of Vermont’s DexCom DXCM Stock Holding History

Trust Company of Vermont’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$74.5K	Buy	1,122 +145	+15%	+$9.37K	﹤0.01%	503
2025 Q3	$65.7K	Buy	977 +837	+598%	+$66.2K	﹤0.01%	518
2025 Q2	$12.2K	Hold	140	–	–	﹤0.01%	790
2025 Q1	$9.56K	Hold	140	–	–	﹤0.01%	773
2024 Q4	$10.9K	Hold	140	–	–	﹤0.01%	762
2024 Q3	$9.39K	Buy	140 +68	+94%	+$5.58K	﹤0.01%	760
2024 Q2	$8.16K	Hold	72	–	–	﹤0.01%	709
2024 Q1	$9.99K	Buy	72 +21	+41%	+$2.64K	﹤0.01%	686
2023 Q4	$6.33K	Buy	51 +1	+2%	+$102	﹤0.01%	646
2023 Q3	$4.67K	Sell	50 -30	-38%	-$3.38K	﹤0.01%	716
2023 Q2	$10.3K	Hold	80	–	–	﹤0.01%	667
2023 Q1	$9.29K	Sell	80 -48	-38%	-$5.37K	﹤0.01%	717
2022 Q4	$14.5K	Hold	128	–	–	﹤0.01%	631
2022 Q3	$10K	Hold	128	–	–	﹤0.01%	716
2022 Q2	$10K	Buy	+128	New	+$11.7K	﹤0.01%	679
2022 Q1	–	Sell	-144	Closed	-$19K	–	423
2021 Q4	$19K	Buy	+144	New	+$20.7K	﹤0.01%	591
2021 Q3	–	Sell	-256	Closed	-$27K	–	417
2021 Q2	$27K	Hold	256	–	–	﹤0.01%	536
2021 Q1	$23K	Sell	256 -184	-42%	-$17.3K	﹤0.01%	537
2020 Q4	$41K	Hold	440	–	–	﹤0.01%	471
2020 Q3	$45K	Sell	440 -12	-3%	-$1.25K	﹤0.01%	439
2020 Q2	$46K	Hold	452	–	–	﹤0.01%	449
2020 Q1	$30K	Hold	452	–	–	﹤0.01%	504
2019 Q4	$25K	Hold	452	–	–	﹤0.01%	571
2019 Q3	$17K	Hold	452	–	–	﹤0.01%	650
2019 Q2	$17K	Hold	452	–	–	﹤0.01%	658
2019 Q1	$13K	Hold	452	–	–	﹤0.01%	672
2018 Q4	$14K	Hold	452	–	–	﹤0.01%	674
2018 Q3	$16K	Buy	+452	New	+$14K	﹤0.01%	726

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Trust Company of Vermont's DXCM Position: Q4 2025 in Review

Trust Company of Vermont increased its DexCom (DXCM) stake by 15% in Q4 2025, buying an estimated $9.37K and bringing the position to 1,122 shares worth $74.5K. The position accounts for ﹤0.01% of the portfolio, ranked #503.

Trust Company of Vermont first reported a position in DXCM in Q3 2018 and has held it in 28 quarters since. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Trust Company of Vermont held 1,122 shares of DexCom worth $74.5K as of Q4 2025.
Trust Company of Vermont bought 145 DexCom shares in Q4 2025, an estimated $9.37K.
DexCom made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #503 holding.
Trust Company of Vermont first reported a position in DexCom in Q3 2018 and has held it in 28 quarters since.
921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.